TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-κB pathway and ERK activation

Journal of Cellular Physiology

Volumn 230, Issue 7, 2015, Pages 1580-1593

  Berzal, Sergio ^a   González Guerrero, Cristian ^a   Rayego Mateos, Sandra ^b   Ucero, Álvaro ^a   Ocaña Salceda, Carlos ^a   Egido, Jesús ^a,c   Ortiz, Alberto ^a,c   Ruiz Ortega, Marta ^b   Ramos, Adrián M ^a  

^a 28400 Madrid   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Section of Nephrology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CADHERIN; CADHERIN 16; CYTOKINE; F ACTIN; HEPATOCYTE NUCLEAR FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; TNFSF12 PROTEIN, HUMAN; TNFSF12 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KIDNEY DISEASE; KIDNEY TUBULE CELL; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; TIGHT JUNCTION; WILD TYPE; ANIMAL; CELL LINE; CYTOLOGY; DOG; GENE EXPRESSION REGULATION; GENETICS; KIDNEY FAILURE; KIDNEY TUBULE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

GASTROPODA; MURINAE;

ANIMALS; CADHERINS; CELL LINE; DOGS; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CALCITRIOL; RENAL INSUFFICIENCY; TIGHT JUNCTION PROTEINS; TUMOR NECROSIS FACTORS;

EID: 84925689973     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24905     Document Type: Article

References (67)

1. Ardura JA, Rayego-Mateos S, Rámila D, Ruiz-Ortega M, Esbrit P. 2010. Parathyroid hormone-related protein promotes epithelial-mesenchymal transition. J Am Soc Nephrol 21:237-248.
2. Bakin AK, Rinehart C, Tomlinson AK, Arteaga CL. 2002. P38 mitogen-activated protein kinase is required for TGFbeta mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115:3193-3206.
3. Barberá MJ, Puig I, Domínguez D, Julien-Grille S, Guaita-Esteruelas S, Peiró S, Baulida J, Francí C, Dedhar S, Larue L, García de Herreros A. 2004. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23:7345-7354.
4. Berzal S, Alique M, Ruiz-Ortega M, Egido J, Ortiz A, Ramos AM. 2012. GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells. Toxicol Sci 127:425-437.
5. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA. 2006. Snail activation, disrupts tissue, homeostasis induces, fibrosis in, the adult, kidney. EMBO J 25:5603-5613.
6. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. 2006. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells J Immunol 176:1889-1898.
7. Carvallo L, Henriquez B, Olate J, van Wijnen AJ, Lian JB, Stein GS, Onate S, Stein JL, Montecino M. 2007. The 1alpha, 25-dihydroxy Vitamin D3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. J Steroid Biochem Mol Biol 103:420-424.
8. Carvajal G, Rodríguez-Vita J, Rodrigues-Díez R, Sánchez-López E, Rupérez M, Cartier C, Esteban V, Ortiz A, Egido J, Mezzano SA, Ruiz-Ortega M. 2008. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 74:585-595.
9. Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J. 2007. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 353:337-343.
10. Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu YH, Sung JS, Cha TL, Sun GH. 2008. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci 99:905-913.
11. Dey M, Baldys A, Sumter DB, Göoz P, Luttrell LM, Raymond JR, Göoz M. 2010. Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement. J Pharmacol Exp Ther 334:775-783.
12. Dohi T, Burkly LC. 2012. The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: Focus on inflammatory bowel diseases. J Leukoc Biol 92:265-279.
13. Eadon MT, Haxk BK, Xu C, Ko B, Toback FG, Cunningham PN. 2012. Endotoxemia alters tight junction gene and protein expression in the kidney. Am J Physiol Renal Physiol 303:F821-F830.
14. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM. 2001. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signalregulated kinase 2 activation. Cancer Res 61:4222-4228.
15. Fischer A, Gluth M, Pape UF, Wiedenmann B, Theuring F, Baumgart DC. 2013. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 304:G970-G979.
16. Girshovich A, Vinsonneau C, Perez J, Vandermeersch S, Verpont MC, Placier S, Jouanneau C, Letavernier E, Baud L, Haymann JP. 2012. Ureteral obstruction promotes proliferation and differentiation of the renal urothelium into a bladder-like phenotype. Kidney Int 82:428-435.
17. Gonzalez JE, DiGeronimo RJ, Arthur DE, King JM. 2009. Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells. Free Radic Biol Med 47:1561-1569.
18. Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E, Dubois-Xu YC. 2011. Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients. J Am Soc Nephrol 22:1375-1381.
19. He F, Peng J, Deng XL, Yang LF, Camara AD, Omran A, Wang GL, Wu LW, Zhang CL, Yin F. 2012. Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier. Cytokine. 59:264-272.
20. Hills CE, Jin T, Siamantouras E, Liu IK, Jefferson KP, Squires PE. 2013. 'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: Modulation of adherens junction complex by ketamine. Plos ONE 8:e71819.
21. Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH. 2012. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res 10:1109-1119.
22. Ivaska J, Pallari HM, Nevo J, Eriksson JE. 2007. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313:2050-2062.
23. Iwano M. 2010. EMT and TGF-beta in renal fibrosis. Front Biosci (Schol Ed) 2:229-238.
24. Justo P, Sanz AB, Sanchez-Niño MD, Winkles JA, Lorz C, Egido J, Ortiz A. 2006. Cytokine cooperation in renal tubular cell injury: The role of TWEAK. Kidney Int 70:1750-1758.
25. Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784.
26. Keller SH, Nigam SK. 2003. Biochemical processing of E-cadherin under cellular stress. Biochem Biophys Res Commun 307:215-223.
27. Kimura K, Morita Y, Orita T, Haruta J, Takeji Y, Sonoda KH. 2013. Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide. Invest Ophthalmol Vis Sci 54:2752-2760.
28. Kwon O, Nelson WJ, Sibley R, Huie P, Scandling JD, Dafoe D, Alfrey E, Myers BD. 1998. Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft. J Clin Invest 101:2054-2064.
29. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. 2013. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047-1053.
30. Li Q, Liu BC, Lv LL, Ma KL, Zhang XL, Phillips AO. 2011. Monocytes induce proximal tubular epithelial-mesenchymal transition through NF-kappa B dependent upregulation of ICAM-1. J Cell Biochem 112:1585-1592.
31. Lilienbaum A, Paulin D. 1993. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem 268:2180-2188.
32. Lipschutz JH, Li S, Arisco A, Balkovetz DF. 2005. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby caninekidney strain I and II cells. J Biol Chem 280:3780-3788.
33. Liu Y. 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212-222.
34. Michaelson JS, Wisniacki N, Burkly LC, Putterman C. 2012. Role of TWEAK in lupus nephritis: A bench-to-bedside review. J Autoimmun 39:130-142.
35. Migliori M, Giovannini L, Panichi V, Filippi C, Taccola D, Origlia N, Mannari C, Camussi G. 2005. Treatment with 1, 25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis. Int J Immunopathol Pharmacol 18:779-790.
36. Moreno-Bueno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, Palacios J, Cano A. 2006. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66:9543-9556.
37. Moustakas A, Heldin CH. 2007. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520.
38. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H. 2003. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 170:341-348.
39. Pantuck AJ, An J, Liu H, Rettig MB. 2010. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas. Cancer Res 0:752-761.
40. Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM. 2006. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6:2.
41. Peinado H, Portillo F, Cano A. 2004. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48:365-375.
42. Poritz LS, Garver KI, Tilberg AF, Koltun WA. 2004. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 116:14-18.
43. Poveda J, Tabara LC, Fernandez-Fernandez B, Martin-Cleary C, Sanz AB, Selgas R, Ortiz A, Sanchez-Niño MD. 2013. TWEAK/Fn14 and non-canonical NF-kappaB signaling in kidney disease. Front Immunol 4:447.
44. Prozialeck WC, Edwards JR. 2007. Cell adhesion molecules in chemically-induced renal injury. Pharmacol Ther 114:74-93.
45. Rayego-Mateos S, Morgado-Pascual JL, Sanz AB, Ramos AM, Eguchi S, Batlle D, Pato J, Keri G, Egido J, Ortiz A, Ruiz-Ortega M. 2013. TWEAK transactivation of the Epidermal growth factor receptor mediates renal inflammation. J Pathol 231:480-494.
46. Reichert M, Müller T, Hunziker W. 2000. The PDZ domains of zonula occludens-1 an epitelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem 275:9492-9500.
47. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC. 2006. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17:19-27.
48. Rojas-Rivera J, De La Piedra C, Ramos A, Ortiz A, Egido J. 2010. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant 25:2850-2865.
49. Rodrigues-Díez R, Carvajal-González G, Sánchez-López E, Rodríguez-Vita J, Rodrigues Díez, Selgas R, Ortiz R, Egido A, Mezzano J, Ruiz-Ortega S. 2008. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK. pathways. Pharm Res 25:2447-2461.
50. Ruiz-Ortega M, Ortiz A, Ramos AM. 2014. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease. Curr Opin Nephrol Hypertens 23:93-100.
51. Ryeom SW, Paul D, Goodenough DA. 2000. Truncation mutants of the tight junction protein ZO-1 disrupt corneal epithelial cell morphology. Mol Biol Cell 11:1687-1696.
52. Sáenz-Morales D, Escribese MM, Stamatakis K, García-Martos M, Alegre L, Conde E, Pérez-Sala D, Mampaso F, García-Bermejo ML. 2006. Requirements for proximal tubule epithelial cell detachment in response to ischemia: Role of oxidative stress. Exp Cell Res 312:3711-3727.
53. Sanz AB, Justo P, Sanchez-Niño MD, Blanco-Colio LM, Winkles JA, Kreztler M, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A. 2008. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19:695-703.
54. Sanz AB, Sanchez-Niño MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM, Ruiz-Ortega M, Egido J, Ortiz A. 2009. TWEAK induces proliferation in renal tubular epithelium: A role in uninephrectomy induced renal hyperplasia. J Cell Mol Med 13:3329-3342.
55. Sanz AB, Sanchez-Niño MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A. 2010. TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: Modulation of CCL21. PLoS ONE 5:e8955.
56. Sanz AB, Sanchez-Niño MD, Ortiz A. 2011. TWEAK, a multifunctional cytokine in kidney injury. Kidney Int 80:708-718.
57. Singh AB, Harris RC. 2004. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem 279:3543-3552.
58. Szaszi K, Amoozadeh Y. 2014. New insights into functions, regulation, and pathological roles of tight junctions in kidney tubular epithelium. Int Rev Cell Mol Biol 308:205-271.
59. Ucero AC, Benito-Martin A, Fuentes-Calvo I, Santamaria B, Blanco J, Lopez-Novoa JM, Ruiz-Ortega M, Egido J, Burkly LC, Martinez-Salgado C, Ortiz A. 2013. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta. 1832:1744-1755.
60. Wilson PD. 2011. Apico-basal polarity in polycystic kidney disease epithelia. Biochim Biophys Acta 1812:1239-1248.
61. Winkles JA. 2008. The TWEAK-Fn14 cytokine-receptor axis: Discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7:411-425.
62. Wu Y, Zhou BP. 2010. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102:639-644.
63. Xia Y, Campbell SR, Broder A, Herlitz L, Abadi M, Wu P, Michaelson JS, Burkly LC, Putterman C. 2012. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin Immunol 145:108-121.
64. Xiong M, Gong J, Liu Y, Xiang R, Tan X. 2012. Loss of vitamin D receptor in chronic kidney disease: A potential mechanism linking inflammation to epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol 303:F1107-F1115.
65. Zhao H, Dong Y, Tian X, Tan TK, Liu Z, Zhao Y, Zhang Y, Harris DCh, Zheng G. 2013. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World J Nephrol 2:84-89.
66. Zheng G, Lyons JG, Tan TK, Wang Y, Hsu TT, Min D, Succar L, Rangan GK, Hu M, Henderson BR, Alexander SI, Harris DC. 2009. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175:580-559.
67. Zhou D, Li Y, Lin L, Zhou L, Igarashi P, Liu Y. 2012. Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice. Kidney Int 82:537-547.